초록 ▼

A method of controlling an intelligent appliance network includes allowing a user to select a desired instruction sequence to be executed by a remote appliance. The instruction sequence contains commands to be completed by both the user and the appliance, as regulated by a CPU, with the sequence bei

A method of controlling an intelligent appliance network includes allowing a user to select a desired instruction sequence to be executed by a remote appliance. The instruction sequence contains commands to be completed by both the user and the appliance, as regulated by a CPU, with the sequence being paused when input is needed by the user and wherein the appliance commands are performed automatically. When applied to a cooking appliance, such as an oven, the appliance will automatically perform certain cooking functions according to a recipe being followed by a CPU. When applied to a washing machine, the factory set operating parameter of the machine can be altered to follow an instructed control sequence applicable to the task performed.

대표청구항 ▼

A method of controlling an intelligent appliance network includes allowing a user to select a desired instruction sequence to be executed by a remote appliance. The instruction sequence contains commands to be completed by both the user and the appliance, as regulated by a CPU, with the sequence bei

A method of controlling an intelligent appliance network includes allowing a user to select a desired instruction sequence to be executed by a remote appliance. The instruction sequence contains commands to be completed by both the user and the appliance, as regulated by a CPU, with the sequence being paused when input is needed by the user and wherein the appliance commands are performed automatically. When applied to a cooking appliance, such as an oven, the appliance will automatically perform certain cooking functions according to a recipe being followed by a CPU. When applied to a washing machine, the factory set operating parameter of the machine can be altered to follow an instructed control sequence applicable to the task performed. least one of cancerous and benign conditions of the breast; and f) Adjusting the power to be delivered to each energy applicator during treatment based on the monitored skin temperatures. 9. The method for treating cancerous or benign conditions of the breast according to claim 8, wherein the focused energy is microwave energy and further comprising the step of maintaining the compression of the breast following the application of microwave energy to the breast tissue in order to accumulate added thermal dose in the treated breast tissue while the breast skin surface temperature is cooled. 10. The method for treating cancerous or benign conditions of the breast according to claim 8, wherein one of chemotherapy, gene therapy including gene based modifiers, thermosensitive liposomes containing chemotherapy, and radiation therapy is used in conjunction with selective irradiation of the breast tissue with focused energy. 11. The method for treating cancerous or benign conditions of the breast according to claim 8, further comprising the step of administering Adriamycin (Doxorubicin) and Cytoxan (Cyclophosphamide) for four cycles, wherein steps a)-f) are conducted for up to three cycles within approximately 36 hours from the time a cycle of Adriamycin/Cytoxan is administered. 12. The method for treating cancerous or benign conditions of the breast according to claim 11, wherein approximately 60 mg/m2of Adriamycin (Doxorubicin) and approximately 600 mg/m2of Cytoxan (Cyclophosphamide) is administered each cycle and approximately 21 days elapse between each cycle. 13. The method for treating cancerous or benign conditions of the breast according to claim 8, further comprising the step of administering up to four cycles of Adriamycin (Doxorubicin) at approximately 60 mg/m2and Cytoxan (Cyclophosphamide) at approximately 600 mg/m2where each cycle is administered approximately every 21 days; and wherein steps a)-f) is one cycle of thermotherapy treatment and at least one thermotherapy treatment is administered after the first cycle of Adriamycin/Cytoxan is completed or approximately 21 days after the first cycle of Adriamycin/Cytoxan is infused into the blood stream of a patient. 14. The method for treating cancerous or benign conditions of the breast according to claim 8, wherein steps a)-f) is one cycle of thermotherapy treatment and thermotherapy is used in combination with at least one of chemotherapy, radiation therapy and gene-based modifiers therapy following a lumpectomy to treat residual ductal carcinoma in-situ. 15. The method for treating cancerous or benign conditions of the breast according to claim 8, wherein steps a)-f) is one cycle of thermotherapy treatment and the thermotherapy treatment is used following a lumpectomy to treat residual ductal carcinoma in-situ. 16. The method for treating cancerous or benign conditions of the breast according to claim 8, wherein steps a)-f) is one cycle of thermotherapy treatment and a cycle of thermotherapy is applied prior to an incision to remove cancerous or benign conditions of the breast so that margins surrounding the cancerous or benign conditions that is to be removed surgically are treated pre-surgery to reduce the amount of at least one of cancerous cells, mutant cells and abnormal cells in the margins and thus the rate of additional incisions. 17. The method for treating cancerous or benign conditions of the breast according to claim 16, wherein thermosensitive liposome treatment is used in combination with the thermotherapy treatment to enhance the destruction of at least one of cancerous cells, mutant cells and abnormal cells in the margins. 18. The method for treating cancerous or benign conditions of the breast according to claim 8, further comprising the step of administering one of Doxorubicin and Docetaxel, and FAC (5-Fluorouracil, Doxorubicin, and cyclophosphamide) in combination with up to four cycles of thermothera